The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EFS24 as a predictor of outcome in a population-based cohort of patients with DLBCL in British Columbia (BC).
 
Line Srour
No Relationships to Disclose
 
Yvonne Y. Zheng
No Relationships to Disclose
 
Alina S. Gerrie
Honoraria - Abbvie; Janssen; Lundbeck
Research Funding - Lundbeck; Roche
 
Kerry J. Savage
Honoraria - Bristol-Myers Squibb; Merck; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Seagen
Speakers' Bureau - Seagen
Research Funding - Roche (Inst)
 
David W. Scott
Honoraria - Celgene; Roche/Genentech
Consulting or Advisory Role - Celgene
Patents, Royalties, Other Intellectual Property - NanoString Technologies
 
Diego Villa
Honoraria - Celgene; Lundbeck; Roche; Seagen
Consulting or Advisory Role - Celgene; Lundbeck; Roche; Seagen
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Lundbeck; Roche
 
Graham W Slack
Consulting or Advisory Role - Seagen
 
Randy D. Gascoyne
Honoraria - Celgene; Seagen
Consulting or Advisory Role - Celgene; Roche; Seagen
Speakers' Bureau - Seagen
 
Joseph M. Connors
Research Funding - Millennium; Roche; Seagen
 
Laurie Helen Sehn
Honoraria - Abbvie; Amgen; Celgene; Gilead Sciences; Janssen; Lundbeck; Roche/Genentech; Seagen; TG Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Janssen; Lundbeck; Roche/Genentech; Seagen; TG Therapeutics
Expert Testimony - Abbvie